Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EPRX.TO | DRUG.CN | NGEN.VN | ||
| Company | Eupraxia Pharmaceuticals Inc | Bright Minds Biosciences Inc | Nervgen Pharma Corp | ||
| Price Information | |||||
| Exchange | TSX | CNSX | TSX Venture | ||
| Open | 11.30 | 109.0800 | 5.650 | ||
| High | 11.31 | 111.2500 | 5.650 | ||
| Low | 10.96 | 108.2800 | 5.350 | ||
| Latest | 11.04 | 108.6400 | 5.410 | ||
| Change | -0.33 | -2.3900 | -0.290 | ||
| % Change | -2.90% | -2.15% | -5.09% | ||
| Volume | 149,564 | 700 | 34,690 | ||
| 20-Day Average Volume | 105,218 | 515 | 59,724 | ||
| Previous Close | 11.37 | 111.0300 | 5.700 | ||
| Industry | TSX Biotechnology | N/A | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 11.40 | 110.5455 | 5.605 | ||
| 20-Day Raw Stochastic | 40.95% | 36.00% | 23.81% | ||
| 20-Day Relative Strength | 48.98 | 47.88 | 42.91 | ||
| Weighted Alpha | +88.32 | +95.08 | +43.27 | ||
| Today's Opinion | 64% Buy | 56% Buy | 24% Buy | ||
| Previous Opinion | 80% Buy | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.90% since 02/24/26 | -5.90% since 02/23/26 | -4.25% since 02/24/26 | ||
| Low | 10.94 on 02/26/26 | 108.2800 on 03/03/26 | 5.350 on 03/03/26 | ||
| High | 11.70 on 03/02/26 | 124.0000 on 02/25/26 | 5.850 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | -9.95% since 02/03/26 | +2.08% since 02/03/26 | -6.56% since 02/03/26 | ||
| Low | 10.09 on 02/19/26 | 100.0000 on 02/04/26 | 5.210 on 02/05/26 | ||
| High | 12.24 on 02/04/26 | 124.0000 on 02/25/26 | 6.050 on 02/23/26 | ||
| 3-Month | |||||
| %Chg | +33.82% since 12/03/25 | +7.09% since 12/03/25 | -12.18% since 12/03/25 | ||
| Low | 8.06 on 12/04/25 | 98.9400 on 01/05/26 | 5.110 on 02/02/26 | ||
| High | 12.86 on 01/21/26 | 170.0000 on 01/06/26 | 8.490 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +47.20% since 09/03/25 | +101.22% since 09/03/25 | +49.86% since 09/03/25 | ||
| Low | 7.15 on 09/16/25 | 55.2200 on 09/09/25 | 3.200 on 11/06/25 | ||
| High | 12.86 on 01/21/26 | 170.0000 on 01/06/26 | 8.490 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 662,365 | 1,086,668 | 451,511 | ||
| Shares Outstanding, K | 58,255 | 9,787 | 79,213 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -25,502,536 | -12,229,348 | -24,005,895 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -6,361,367 | -7,565,318 | -4,156,070 | ||
| 60-Month Beta | 1.72 | -6.53 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/04/25 | -0.97 on 02/13/26 | -0.06 on 11/24/25 | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||